HCK - HCK proto-oncogene, Src family tyrosine kinase Gene

中文名称：HCK 原癌基因，Src 家族酪氨酸激酶

种属: Homo sapiens

同用名: JTK9; p59Hck; p61Hck

基因 ID: 3055 | 基因类型: protein coding

关于 HCK

Cytogenetic location: 20q11.21 Genomic coordinates (GRCh38): 20:32,052,242-32,101,856 (from NCBI)

This gene has 8 transcripts (splice variants), 205 orthologues and 32 paralogues. Broad expression in appendix (RPKM 55.1), spleen (RPKM 40.9) and 14 other tissues.

功能概要

该基因编码的蛋白质是酪氨酸激酶 Src 家族的成员。这种蛋白质主要是造血的，特别是在骨髓和 B 淋巴细胞谱系的细胞中。它可能有助于将 Fc 受体与呼吸爆发的激活结合起来。此外，它可能在中性粒细胞迁移和中性粒细胞脱颗粒中发挥作用。由于选择性剪接和使用替代翻译起始密码子，包括非 AUG (CUG) 密码子，会产生具有不同亚细胞分布的多种亚型。[RefSeq 提供，2010 年 2 月]

The protein encoded by this gene is a member of the Src family of tyrosine kinases. This protein is primarily hemopoietic, particularly in cells of the myeloid and B-lymphoid lineages. It may help couple the Fc receptor to the activation of the respiratory burst. In addition, it may play a role in neutrophil migration and in the degranulation of neutrophils. Multiple isoforms with different subcellular distributions are produced due to both alternative splicing and the use of alternative translation initiation codons, including a non-AUG (CUG) codon. [provided by RefSeq, Feb 2010]

HCK 基因产物(6)

mRNA	Protein	Name
NM_001172129.3	NP_001165600.1	tyrosine-protein kinase HCK isoform b
NM_001172130.3	NP_001165601.1	tyrosine-protein kinase HCK isoform c
NM_001172131.3	NP_001165602.1	tyrosine-protein kinase HCK isoform d
NM_001172132.3	NP_001165603.1	tyrosine-protein kinase HCK isoform e
NM_001172133.3	NP_001165604.1	tyrosine-protein kinase HCK isoform b
NM_002110.5	NP_002101.2	tyrosine-protein kinase HCK isoform a

基因本体论

分子功能
生物过程
细胞组分

分子功能 GO 注释	逻辑证据	参考文献	来源
enables lipid binding	EXP EXP: 通过实验结果推断	31877324	GOA
enables phosphotyrosine residue binding	IPI IPI: 通过物理相互作用推断	20624904	GOA
enables protein binding	IPI IPI: 通过物理相互作用推断	7859737	GOA
enables protein tyrosine kinase activity	EXP EXP: 通过实验结果推断	10861086	GOA
enables protein tyrosine kinase activity	IMP IMP: 通过突变表型推断	10092522	GOA

生物过程 GO 注释	逻辑证据	参考文献	来源
involved in intracellular signal transduction	IMP IMP: 通过突变表型推断	11904303	GOA
involved in negative regulation of apoptotic process	IMP IMP: 通过突变表型推断	17535448	GOA
involved in peptidyl-tyrosine phosphorylation	IMP IMP: 通过突变表型推断	10092522	GOA
involved in positive regulation of cell population proliferation	IMP IMP: 通过突变表型推断	10092522	GOA
involved in protein autophosphorylation	IMP IMP: 通过突变表型推断	10092522	GOA
involved in regulation of DNA-binding transcription factor activity	IMP IMP: 通过突变表型推断	17535448	GOA
involved in regulation of actin cytoskeleton organization	IMP IMP: 通过突变表型推断	11904303	GOA
involved in regulation of cell shape	IMP IMP: 通过突变表型推断	10092522	GOA
involved in regulation of phagocytosis	IMP IMP: 通过突变表型推断	11904303	GOA
involved in regulation of podosome assembly	IDA IDA: 通过直接分析推断	15998323	GOA

细胞组分 GO 注释	逻辑证据	参考文献	来源
colocalizes with actin filament	IDA IDA: 通过直接分析推断	15998323	GOA
located in caveola	IDA IDA: 通过直接分析推断	7791757	GOA
located in cytoplasmic side of plasma membrane	IMP IMP: 通过突变表型推断	11904303	GOA
located in focal adhesion	IMP IMP: 通过突变表型推断	11904303	GOA
located in lysosome	IDA IDA: 通过直接分析推断	15998323	GOA

EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

HCK 蛋白结构

SH3_1

SH2

Pkinase_Tyr

0
100
200
300
400
506 a.a.

蛋白主名

其他名称

tyrosine-protein kinase HCK

hematopoietic cell kinase

关联疾病

疾病名称

别名

Renal Pelvis Adenocarcinoma

Adenocarcinoma Of Renal Pelvis

Adenocarcinoma Of The Kidney Pelvis

Leukemia, Chronic Myeloid

Chronic Myeloid Leukemia	Chronic Myelogenous Leukemia
CML	Chronic Granulocytic Leukemia
Leukemia, Philadelphia Chromosome-Positive, Resistant To Imatinib	Chronic Myeloid Leukaemia
Chronic Granulocytic Leukaemia	Chronic Myelogenous Leukaemia
Myeloid Leukemia, Chronic	Leukemia, Chronic Myelogenous
Leukemia, Chronic Myeloid, Philadelphia Chromosome Positive, Somatic	Cml - Chronic Myelogenous Leukemia
Cgl	Chronic Myelocytic Leukemia
Leukemia, Chronic Myeloid, Atypical	ACML
Atypical Chronic Myeloid Leukemia Bcr-Abl1 Negative	Myeloid Leukemia Chronic
Leukemia, Myeloid, Chronic	Leukemia, Myeloid, Chronic, Atypical, Bcr-Abl Negative
Cml- [Chronic Myeloid Leukaemia]	Cgl - [Chronic Granulocytic Leukaemia]
Chronic Myelocytic Leukaemia

Human Immunodeficiency Virus Type 1

Aids	Hiv/Aids
Aids, Delayed/Rapid Progression To	Hiv-1, Susceptibility To
Hiv-1 Viremia, Susceptibility To	Human Immunodeficiency Virus Type 1, Susceptibility To
Hiv-1	Aids, Slow Progression To
Rapid Progression To Aids From Hiv1 Infection	Hiv1 Infection, Resistance To
Hiv1 Infection	Hiv-1 Viremia
Aids, Resistance To	Aids, Rapid Progression To
Hiv/Aids, Susceptibility To	Hiv-1, Resistance To
Hiv1, Resistance To	Hiv1
Hiv-1 Disease, Delayed Progression Of	Hiv-1 Disease, Rapid Progression Of
Hiv Infection, Resistance To	Hiv Type 1, Susceptibility To
Hiv Type 1	Hiv-1 Infection
Human Immunodeficiency Virus I Infection	Acquired Immunodeficiency Syndrome
Hiv-Infection/Aids

Cd45 Deficiency

Lung Clear Cell Carcinoma

Co-Trimoxazole Allergy

Bactrim Allergy	Cotrimoxazol Allergy
Tmp/Smx Allergy	Trimethoprim/Sulfamethoxazole Allergy

Immune Deficiency Disease

Immunodeficiency	Primary Immunodeficiency
Primary Immunodeficiency Disease	Immunologic Deficiency Syndromes
Hypoimmunity	Immune Deficiency Disorder
Immunodeficiency Syndrome	Immune Disorder
Primary Immune Deficiency Disorder	Immune System Diseases
Human Immunodeficiency Virus Infection	Hiv - [Human Immunodeficiency Virus Infection]
Hiv Positive Nos	Hiv Disease
Acquired Immune Deficiency Syndrome-Related Complex	Aids-Like Syndrome
Aids-Related Complex Nos	Arc - [Aids-Related Complex]
Immunodeficiency Due To Human Immunodeficiency Virus Infection	Unspecified Human Immunodeficiency Virus Disease
Hiv Disease Nos	Human Immunodeficiency Virus Positive Nos
Hiv Nos	Deficiency Of Complement Initial Pathway
Deficiency Of Complement Terminal Pathway	Cfdd - [Complement Factor D Deficiency]
Immunodeficiency With Nk-Cell - [Natural-Killer Cell] Deficiency	Nonfamilial Hypogammaglobulinaemia
Common Variable Immune Deficiency	Nonfamilial Agammaglobulinaemia
Common Variable Agammaglobulinaemia	Agammaglobulinaemia Nos
Agammaglobulinaemia Antibody Deficiency Syndrome	Hypogammaglobulinaemia Antibody Deficiency Syndrome
Acquired Agammaglobulinaemia Nos	Hypogammaglobulinaemia Nos
Hyper Igm

Leukemia, Acute Lymphoblastic

Acute Lymphoblastic Leukemia	ALL
Acute Lymphocytic Leukemia	Leukemia, Acute Lymphocytic, Susceptibility To, 1
Acute Lymphoblastic Leukaemia	Precursor Lymphoblastic Lymphoma/Leukemia
Precursor Lymphoid Neoplasm	Leukemia, Acute Lymphoblastic, Susceptibility To
B-Cell Acute Lymphoblastic Leukemia	Leukemia, Acute Lymphocytic 1
Acute Lymphocytic Leukaemia	Acute Lymphoblastic Leukemia/Lymphoma
All1	Childhood Acute Lymphoblastic Leukemia
Leukemia Acute Lymphoblastic 1	Leukemia Acute Lymphoblastic B-Hyperdiploid
Leukemia Acute Lymphocytic	Leukemia Acute Lymphocytic 1
Leukemia B-Cell Acute Lymphoblastic	Leukemia T-Cell Acute Lymphoblastic
Leukemia, Acute Lymphoblastic, 3	ALL3
Lymphoblastic Leukemia Acute	Leukemia, Acute, Lymphoblastic
Precursor Cell Lymphoblastic Leukemia Lymphoma	Leukemia, Lymphocytic, Acute, L1
Leukemia, Acute Lymphoblastic, Susceptibility To, 3

Thrombocytopenia

Low Platelet Count	Low Platelets
Decreased Platelets	Platelet Dysfunction Nos

疾病名称	别名
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

目录号	产品名	作用方式	纯度	Phase
HY-10186	TG 100801	Inhibitor	98.61%	Phase 2
HY-10187	TG 100801 Hydrochloride	Inhibitor	/	Phase 2

Cat. No.	产品名	作用方式	纯度	是否罕见病
HY-112852	TL02-59		99.84%	否
HY-139147	iHCK-37	Inhibitor	99.52%	否
HY-18009	(Z)-LFM-A13	Inhibitor	99.80%	否
HY-155657	BT424	Inhibitor	98.81%	否
HY-P3279	EPQpYEEIPIYL	Activator	99.62%	否
HY-10185	TG 100572 Hydrochloride	Inhibitor	98.96%	否
HY-D1694	LysoTracker Yellow HCK 123		98.51%	否
HY-15805	KIN-8194	Inhibitor	98.01%	否
HY-120595	JNJ-49095397	Inhibitor	99.85%	否
HY-125028	Hck-IN-1	Inhibitor	98.53%	否
HY-123450	S116836		99.65%	否
HY-10184	TG 100572	Inhibitor	/	否
HY-112852A	TL02-59 dihydrochloride		/	否
HY-135216	Antiproliferative agent-54	Inhibitor	/	否
HY-138562	HIV-1 Nef-IN-1	Inhibitor	98.60%	否
HY-147314	HIV-IN-6	Inhibitor	98.35%	否
HY-15268	PP487	Inhibitor	/	否
HY-RS06044	HCK Human Pre-designed siRNA Set A	Pre-designed Sets	/	否

直系同源

种属	基因名	来源	基因 ID
Bos taurus	HCK	VGNC	VGNC:29774
Rattus norvegicus	HCK	RGD	RGD:2785
Canis familiaris	HCK	VGNC	VGNC:41618
Mus musculus	HCK	MGD	MGI:96052
Felis catus	HCK	VGNC	VGNC:67542
Macaca mulatta	HCK	VGNC	VGNC:73353
Others	HCK	NCBI

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4